Zoetis Inc. $ZTS Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. trimmed its position in shares of Zoetis Inc. (NYSE:ZTS) by 14.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 119,919 shares of the company’s stock after selling 19,696 shares during the period. Pacer Advisors Inc.’s holdings in Zoetis were worth $17,547,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the company. Blue Zone Wealth Advisors LLC grew its holdings in Zoetis by 6.5% during the 3rd quarter. Blue Zone Wealth Advisors LLC now owns 34,746 shares of the company’s stock worth $5,084,000 after acquiring an additional 2,120 shares in the last quarter. Cornercap Investment Counsel Inc. acquired a new stake in shares of Zoetis in the 3rd quarter valued at $1,598,000. Curbstone Financial Management Corp lifted its position in shares of Zoetis by 1.6% during the 3rd quarter. Curbstone Financial Management Corp now owns 11,790 shares of the company’s stock worth $1,725,000 after purchasing an additional 180 shares during the last quarter. ZWJ Investment Counsel Inc. grew its stake in shares of Zoetis by 33.0% during the third quarter. ZWJ Investment Counsel Inc. now owns 2,410 shares of the company’s stock worth $353,000 after purchasing an additional 598 shares in the last quarter. Finally, Alhambra Investment Management LLC acquired a new position in shares of Zoetis during the third quarter worth $252,000. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

ZTS has been the topic of a number of analyst reports. Stifel Nicolaus cut their price target on Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a research note on Tuesday, November 18th. BTIG Research reissued a “buy” rating and set a $160.00 target price on shares of Zoetis in a research report on Wednesday, December 3rd. UBS Group lowered their price target on Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. Argus reissued a “buy” rating and set a $190.00 price objective on shares of Zoetis in a report on Tuesday, September 9th. Finally, Bank of America downgraded shares of Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 price objective for the company. in a research report on Monday, December 15th. Six analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $160.18.

Zoetis Trading Up 0.5%

ZTS opened at $126.16 on Friday. The firm has a market cap of $55.60 billion, a price-to-earnings ratio of 21.24, a price-to-earnings-growth ratio of 2.74 and a beta of 0.97. Zoetis Inc. has a 52 week low of $115.25 and a 52 week high of $177.40. The business’s 50 day moving average is $127.05 and its two-hundred day moving average is $142.97. The company has a quick ratio of 2.28, a current ratio of 3.64 and a debt-to-equity ratio of 1.31.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.08. The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The company’s revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts predict that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 3rd. Shareholders of record on Tuesday, January 20th will be given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, January 20th. This is an increase from Zoetis’s previous quarterly dividend of $0.50. Zoetis’s payout ratio is 35.69%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.